Log In
Print
BCIQ
Print
Print this Print this
 

TAS-115

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionLow-molecular-weight receptor tyrosine kinase inhibitor targeting MET and VEGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionMET inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today